Meng‐Chi Yen
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 8
- Cancer-related molecular mechanisms research 7
- Cancer, Lipids, and Metabolism 6
- Biological Psychiatry top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses 10
- Oncology top 5%
- Molecular Biology top 10%
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 6
- Metabolomics and Mass Spectrometry Studies 5
-
- Cancer Research and Treatments 7
- Co-authors
- Po‐Lin KuoChih‐Yang WangMing-Derg LaiYa‐Ling HsuHui‐Ping HsuTzu‐Yang WengYi‐Ling ChenWei-Ching Chen
- Partner nations
- TaiwanUnited StatesVietnam
In The Last Decade
Meng‐Chi Yen
79 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 590
- Biological Psychiatry 58
- Immunology 417
- Oncology 466
- Molecular Biology 1.1k
Countries citing papers authored by Meng‐Chi Yen
This map shows the geographic impact of Meng‐Chi Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Chi Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Chi Yen more than expected).
Fields of papers citing papers by Meng‐Chi Yen
This network shows the impact of papers produced by Meng‐Chi Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Chi Yen. The network helps show where Meng‐Chi Yen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng‐Chi Yen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 37 | |
| 7 | 2018 | 15 | |
| 8 | 2017 | 12 | |
| 9 | 2017 | 45 | |
| 10 | 2016 | 8 | |
| 11 | 2016 | 11 | |
| 12 | 2015 | 46 | |
| 13 | 2014 | 13 | |
| 14 | 2014 | 19 | |
| 15 | 2013 | 5 | |
| 16 | 2011 | 28 | |
| 17 | 2010 | 15 | |
| 18 | 2010 | 18 | |
| 19 | 2009 | 74 | |
| 20 | 2009 | 26 |
About Meng‐Chi Yen
Meng‐Chi Yen is a scholar working on Biological Psychiatry, Cancer Research and Immunology, having authored 81 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer Research and Treatments (7 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer, Lipids, and Metabolism (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Cancer Research (590 citations), Biological Psychiatry (58 citations) and Immunology (417 citations). Meng‐Chi Yen has collaborated with scholars based in Taiwan, United States and Vietnam. Frequent co-authors include Po‐Lin Kuo, Chih‐Yang Wang, Ming-Derg Lai, Ya‐Ling Hsu, Hui‐Ping Hsu, Tzu‐Yang Weng, Yi‐Ling Chen, Wei-Ching Chen, Ming‐Derg Lai and Chi‐Chen Lin. Their work appears in journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.